NORTHPOINTE CAPITAL LLC - GEMPHIRE THERAPEUTICS INC ownership

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 31 filers reported holding GEMPHIRE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHPOINTE CAPITAL LLC ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$229,000
-76.9%
282,233
-41.5%
0.05%
-63.6%
Q3 2018$993,000
-86.1%
482,134
-31.0%
0.14%
-84.9%
Q2 2018$7,121,000
+40.4%
698,802
-10.3%
0.94%
+48.7%
Q1 2018$5,072,000
+20.3%
779,109
+46.9%
0.64%
+34.5%
Q4 2017$4,215,000
-14.7%
530,547
+2.0%
0.47%
-10.6%
Q3 2017$4,943,000
+42.4%
520,292
+91.8%
0.53%
+45.5%
Q2 2017$3,472,000271,2150.36%
Other shareholders

There were no reported owners of GEMPHIRE THERAPEUTICS INC in Q3 2018.

NameSharesValueWeighting ↓
View complete list of GEMPHIRE THERAPEUTICS INC shareholders